Skip to main content
TipRanks
Go Ultimate75% OFF

Livzon Pharmaceutical Group (LVZPF) Stock Statistics & Valuation Metrics

5 Followers

Total Valuation

Livzon Pharmaceutical Group has a market cap or net worth of $3.75B. The enterprise value is $17.84B.

Market Cap
$3.75B
Enterprise Value
$17.84B

Share Statistics

Livzon Pharmaceutical Group has 299,807,130 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
299,807,130
Owned by Insiders
―
Owned by Institutions
5.92%

Financial Efficiency

Livzon Pharmaceutical Group’s return on equity (ROE) is 0.15 and return on invested capital (ROIC) is 12.50%.

Return on Equity (ROE)
0.15
Return on Assets (ROA)
0.08
Return on Invested Capital (ROIC)
12.50%
Return on Capital Employed (ROCE)
0.18
Revenue Per Employee
1.35M
Profits Per Employee
227.89K
Employee Count
8,878
Asset Turnover
0.50
Inventory Turnover
2.62

Valuation Ratios

The current PE Ratio of Livzon Pharmaceutical Group is 18.10. Livzon Pharmaceutical Group’s PEG ratio is -0.67.

PE Ratio
18.10
PS Ratio
2.45
PB Ratio
2.16
Price to FCF
9.06
Price to Operating Cash Flow
8.86
PEG Ratio
-0.67

Income Statement

In the last 12 months, Livzon Pharmaceutical Group had revenue of 12.02B and earned 2.02B in profits. Earnings per share was 2.27.

Revenue
12.02B
Gross Profit
7.92B
Operating Income
2.95B
Pretax Income
2.86B
Net Income
2.02B
EBITDA
3.10B
Earnings Per Share (EPS)
2.27

Cash Flow

In the last 12 months, operating cash flow was 3.20B and capital expenditures -414.85M, giving a free cash flow of 2.79B billion.

Operating Cash Flow
3.20B
Free Cash Flow
2.79B
Free Cash Flow per Share
3.11

Dividends & Yields

Livzon Pharmaceutical Group pays an annual dividend of $0.21, resulting in a dividend yield of 3.86%

Dividend Per Share
$0.21
Dividend Yield
3.86%
Payout Ratio
65.69%
Free Cash Flow Yield
11.04%
Earnings Yield
5.54%

Stock Price Statistics

Beta
0.29
52-Week Price Change
-27.22%
50-Day Moving Average
3.72
200-Day Moving Average
3.79
Relative Strength Index (RSI)
99.97
Average Volume (3m)
―

Important Dates

Livzon Pharmaceutical Group upcoming earnings date is Mar 31, 2027, TBA (Not Confirmed).

Last Earnings Date
Oct 23, 2026
Next Earnings Date
Mar 31, 2027
Ex-Dividend Date
Jun 17, 2026

Financial Position

Livzon Pharmaceutical Group as a current ratio of 2.23, with Debt / Equity ratio of 27.69%

Current Ratio
2.23
Quick Ratio
2.02
Debt to Market Cap
0.17
Net Debt to EBITDA
-1.76
Interest Coverage Ratio
48.99

Taxes

In the past 12 months, Livzon Pharmaceutical Group has paid 451.01M in taxes.

Income Tax
451.01M
Effective Tax Rate
0.16

Enterprise Valuation

Livzon Pharmaceutical Group EV to EBITDA ratio is 9.38, with an EV/FCF ratio of 7.95.

EV to Sales
2.15
EV to EBITDA
9.38
EV to Free Cash Flow
7.95
EV to Operating Cash Flow
6.92

Balance Sheet

Livzon Pharmaceutical Group has $7.31B in cash and marketable securities with $4.20B in debt, giving a net cash position of $3.11B billion.

Cash & Marketable Securities
$7.31B
Total Debt
$4.20B
Net Cash
$3.11B
Net Cash Per Share
$10.38
Tangible Book Value Per Share
$13.70

Margins

Gross margin is 60.53%, with operating margin of 19.25%, and net profit margin of 15.23%.

Gross Margin
60.53%
Operating Margin
19.25%
Pretax Margin
21.50%
Net Profit Margin
15.23%
EBITDA Margin
22.91%
EBIT Margin
19.83%

Analyst Forecast

The average price target for Livzon Pharmaceutical Group is $4.37, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target
$4.37
Price Target Upside
14.95% Upside
Analyst Consensus
Moderate Buy
Analyst Count
2
Revenue Growth Forecast
-9.78%
EPS Growth Forecast
-23.43%

Scores

Smart Score
7
AI Score
―